Frank L. Hurley
Direttore Tecnico/Scientifico/R&S presso Symphony Dynamo, Inc.
Provenienza dei contatti di primo grado di Frank L. Hurley
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Symphony Dynamo, Inc.
Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Symphony Evolution, Inc.
Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE.
4
| Private Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Frank L. Hurley tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
AGENUS INC. | Biotechnology | Director/Board Member Director/Board Member | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer | |
Seqirus Vaccines Ltd.
Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | President | |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | President | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
ORGANOVO HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Brown University | College/University | Undergraduate Degree | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
University of Pennsylvania | College/University | Doctorate Degree | |
Genesis Engineering Consultants
Genesis Engineering Consultants Miscellaneous Commercial ServicesCommercial Services Part of Aker ASA, Genesis Engineering Consultants is a British company that provides oil and gas related consulting services. The company is based in Aberdeen, UK. Genesis Engineering Consultants was acquired by Aker Maritime ASA on August 25, 1998. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shearman & Sterling LLP
Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BRI International, Inc.
BRI International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
University of St. Andrews | College/University | Doctorate Degree | |
University of Genoa | College/University | Doctorate Degree | |
Symphony Capital LLC
Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Founder Founder | |
Symphony Genisis, Inc.
Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Founder Director of Finance/CFO Chief Executive Officer | |
Fondation Santé | Director/Board Member | ||
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
USAir, Inc.
USAir, Inc. Engineering & ConstructionIndustrial Services Part of American Airlines Group, Inc., USAir, Inc. operates as a heating, ventilation and air conditioning contractor company. The company is based in Muscatine, IA. | Engineering & Construction | Corporate Officer/Principal | |
Symphony ViDA, Inc.
Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
RRD International LLC
RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director of Finance/CFO Founder | |
Sol Salins, Inc. | Corporate Officer/Principal | ||
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
The City College of New York | College/University | Undergraduate Degree | |
Syracuse University College of Law | College/University | Graduate Degree | |
Tollys
Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon. | Hospital/Nursing Management | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 33 |
Regno Unito | 4 |
Svizzera | 3 |
Italia | 2 |
Grecia | 2 |
Settori
Health Technology | 16 |
Consumer Services | 11 |
Commercial Services | 8 |
Health Services | 4 |
Government | 2 |
Posizioni
Director/Board Member | 22 |
Corporate Officer/Principal | 16 |
Chief Executive Officer | 8 |
Chairman | 6 |
Director of Finance/CFO | 5 |
Contatti più connessi
Insiders | |
---|---|
Mark Kessel | 18 |
Alastair J. J. Wood | 11 |
Charles W. Finn | 11 |
Dino Dina | 8 |
Harri V. Taranto | 8 |
Daniel R. Salins | 8 |
Ann M. Arvin | 3 |
- Borsa valori
- Insiders
- Frank L. Hurley
- Connessioni Società